We attended Aventis Pharma – APL’s recent annual general meeting (AGM). The management indicated that its focus will be on the domestic formulations business, with rural and OTC segments as the key growth drivers. APL is likely to incur some extra expenditure for establishing its presence in these segments. In CY09, APL launched 15 new [...]
You may also like
{ 0 comments }